|
|
Volumn 18, Issue 2, 2002, Pages 128-129
|
|
Intensive insulin therapy in critically ill patients
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACTIVATED PROTEIN C;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DROTRECOGIN;
FIBRIC ACID DERIVATIVE;
GLUCOSE;
INSULIN;
LITHIUM;
NIFEDIPINE;
OCTREOTIDE;
ORAL CONTRACEPTIVE AGENT;
POTASSIUM;
SODIUM CHLORIDE;
STEROID;
TESTOSTERONE;
BLOOD GLUCOSE MONITORING;
CLINICAL STUDY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CRITICAL ILLNESS;
DEATH;
DOSE RESPONSE;
DRUG EFFECT;
DRUG MECHANISM;
DRUG OVERDOSE;
GLUCOSE BLOOD LEVEL;
HEART SURGERY;
HUMAN;
HYPERNATREMIA;
HYPOGLYCEMIA;
HYPOKALEMIA;
INSULIN TREATMENT;
INTENSIVE CARE;
INTENSIVE CARE UNIT;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
MORTALITY;
MULTIPLE ORGAN FAILURE;
NURSING;
OUTCOMES RESEARCH;
POSTOPERATIVE COMPLICATION;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
RISK ASSESSMENT;
SEPSIS;
SURVIVAL RATE;
|
|
EID: 0036553646
PISSN: 09643397
EISSN: None
Source Type: Journal
DOI: 10.1016/S0964-3397(02)00009-5 Document Type: Article |
|
Times cited : (5)
|
|
References (1)
|
